• Western blot analysis of extracts of various cell lines, using ART5 antibody (STJ29226) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 30s.

Anti-ART5 antibody (23-200) (STJ29226)

SKU:
STJ29226

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-ART5 (23-200) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: ART5
Gene ID: 116969
Uniprot ID: NAR5_HUMAN
Immunogen Region: 23-200
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 23-200 of human ART5 (NP_443750.2).
Immunogen Sequence: VPILPLGLAPDTFDDTYVGC AEEMEEKAAPLLKEEMAHHA LLRESWEAAQETWEDKRRGL TLPPGFKAQNGIAIMVYTNS SNTLYWELNQAVRTGGGSRE LYMRHFPFKALHFYLIRALQ LLRGSGGCSRGPGEVVFRGV GSLRFEPKRLGDSVRLGQFA SSSLDKAVAHRFGNATLF
Protein Name Ecto-Adp-Ribosyltransferase 5
Adp-Ribosyltransferase C2 And C3 Toxin-Like 5
Artc5
Mono(Adp-Ribosyltransferase 5
Nad(P(+--Arginine Adp-Ribosyltransferase 5
Cellular Localisation Secreted
Alternative Antibody Names Anti-Ecto-Adp-Ribosyltransferase 5 antibody
Anti-Adp-Ribosyltransferase C2 And C3 Toxin-Like 5 antibody
Anti-Artc5 antibody
Anti-Mono(Adp-Ribosyltransferase 5 antibody
Anti-Nad(P(+--Arginine Adp-Ribosyltransferase 5 antibody
Anti-ART5 antibody
Anti-UNQ575 antibody
Anti-PRO1137 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance